---
title: 'Senior Mechanical Engineer at Mytos'
canonical: 'https://feeny.ai/job/senior-mechanical-engineer-mytos-london-41kr09a8t7xc'
type: 'job'
last_seen: '2026-09-07'
---

# Senior Mechanical Engineer at Mytos

- **Company:** Mytos
- **Location:** London, United Kingdom
- **Employment:** full-time
- **Work type:** onsite
- **Posted:** 2025-07-15
- **Last confirmed live:** 2026-09-07
- **Apply:** https://jobs.lever.co/mytos/1b1fe1ea-5c17-4d3d-87ba-d2d2ac202682

## Job description

## About Us

You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.

We’ve developed machines to fully automate human cell production - the most manual process in Biotech. Cells are used to discover and develop new drugs, and now they're being used to cure diseases like Parkinson’s and age-related blindness. Mytos will impact cure development across the board.

We're live in multibillion dollar biotechs on both coasts of the US, and raised $19m to expand into the market faster, and accelerate our development! Next year, neurons grown on our machines will be going into Parkinson patient brains.

We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team

Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.

This is an opportunity to work on projects at the interface of engineering and biology. When you join us, you’ll get to:

- Make our devices more indestructible - iterate and improve the robustness and reliability of our machines.
- Lead development of systems that interface to areas you might not be familiar with, such as optics and fluidics.
- Work on all aspects of hardware design - from initial concept through to manufacture.
- Refine and build existing proof-of-concept features and collaborate on integrating new ones.
- Refine our test rigs, quality processes and data, and harness them to improve our sprint velocity and help us move faster.
- Help shape our engineering culture and processes so that we keep continually improving. You’ll enjoy the autonomy, accountability and customer-focus that we bring to our work.

We’d love to hear from you if:

- You’ve brought at least one complex product to market - ideally in the lab automation, medical devices or biotech space, but we’re open to other areas too.
- You have a keen understanding of building reliability into hardware R&D processes.
- Complex systems containing hardware, electronics and software fascinate you. You cannot wait to work on a device that incorporates multiple electro-mechanical systems that move with high precision in tandem with one another.
- The open-source hardware movement interests you, even though your industrial experience may not have touched on things like Adafruit, SparkFun, Arduino and Raspberry Pi. What you do enjoy are non-traditional approaches to prototyping and finding ways to get things working. You might even have learnt to code to get things talking to each other.
- Manufacturing techniques including injection molding, sheet metal fabrication and CNC machining are part of your toolkit

Salary and Benefits:

- Competitive salary with stock options
- Lunch covered daily
- Collaborative team environment with very high potential to learn new skills
- 24 days holiday (excluding bank holidays)
- Pension
- Awesome colleagues and an office in the Imperial College Innovation hub in White City, where you’ll be based.
- Because of the HW device aspect of this role, we are unable to support remote-first working and potential colleagues must be happy to work from our lab.

We’re building a team that enjoys moving fast and not killing cells, strives for continuous improvement through learning from mistakes and is passionate about work that contributes to solving real world problems.

We get excited about meeting potential colleagues from broad scientific/engineering backgrounds and who share our enthusiasm for unconstrained innovation and understanding our users.

## About Mytos

## Company Overview
- **One-liner**: Mytos is building the world’s first fully automated cell manufacturing platform to scale regenerative medicines from clinical trials to millions of patients at low cost.
- **Entity Type**: Private (Series A, $24M+ total funding)
- **Headquarters**: London, United Kingdom
- **Founded**: 2016
- **Founders**: Ali Afshar (CEO) and Ignacio Willats

## Core Business
- **Primary industry**: Biotechnology / Regenerative Medicine / Automated Cell Therapy Manufacturing
- **Target customers**: Clinical-stage cell therapy companies (B2B, Enterprise CDMO), large pharma R&D groups
- **Mission**: To scale regenerative medicines to millions of patients by automating the production of stem cell-derived therapies

## Products & Services
- **iDEM™ Platform**: Proprietary automated cell culture system that uses standard 2D T-flasks to seamlessly port manual protocols into closed, scalable automation without compromising biology. Reduces labour per batch by up to 10x and cleanroom footprint per batch by another 10x.
- **Mytos CDMO**: A fully automated contract development and manufacturing organization (CDMO) powered by iDEM technology. Site 1 is housed within the Cell and Gene Therapy Catapult’s 80,000 sqft facility in Stevenage, UK. Offers end-to-end manufacturing services including Process & Analytical Development, Regulatory Support, and batch production with up to 50% lower batch costs compared to manual CDMOs.

## Market Standing
- **Valuation**: Not publicly disclosed
- **Key Metric**: Total funding of over $24M (Series A led by Buckley Ventures in November 2023; prior rounds include Y Combinator, IQ Capital, and TBD Angels)
- **Notable Investors/Partners**: Y Combinator, Buckley Ventures, IQ Capital; founders/execs from Wayve, Dropbox, Segment, Mercury, Sana, BMS, Revolut; partnerships with Pluristyx, NOVADIP Biosciences, StemSight, and Rinri Therapeutics
- **Growth Signals**: Headcount of ~27 employees (+11.6% YoY); announced three cell therapy manufacturing deals in September 2025; launched automated CDMO in October 2025; first in-patient dosing targeted for 2027; 5 active job postings; strong LinkedIn follower growth (+39.4% yearly)

## Competitive Advantages
- **Biology-preserving automation**: Uses the same 2D T-flask format as manual culture, meaning no need to re-engineer existing protocols — a major barrier to adoption for competing solutions.
- **Fleet architecture**: Unlike large robotic-arm solutions, the iDEM fleet has no single point of failure, increasing reliability for clinical/commercial production.
- **Cost leadership**: Claims up to 50% lower batch costs vs. manual CDMOs and 10x labour reduction, making therapies economically viable at scale.
- **End-to-end CDMO model**: Integrates process development, regulatory support, and manufacturing under one roof, reducing tech transfer delays.

## Strategic Focus
- **Scale the CDMO**: Expand global manufacturing sites beyond the UK (plans in place for a series of global sites).
- **Clinical validation**: Move from R&D partnerships to clinical-stage manufacturing, with cells produced on iDEM entering patients by 2027.
- **Partnership pipeline**: Continue signing deals across multiple therapeutic areas (Parkinson’s, blindness, bone repair, hearing loss) to diversify revenue and de-risk technology.
- **Hiring for growth**: Actively recruiting across engineering, quality, and scientific leadership to support CDMO ramp-up.

## Why Work Here
- **Mission-driven impact**: Directly work on curing Parkinson’s, blindness, and spinal cord injuries at scale — a rare combination of deep tech and patient impact.
- **Culture & team**: Rated 4.5/5 on employer review platforms (Culture: 4.4, Career: 4.6). Team includes engineers from Dyson, Autodesk, and Matic Robots alongside Nature-published scientists.
- **Work location**: On-site in London (HQ at 80 Wood Lane) with additional offices in Newark, California and Billingstad, Norway.
- **Growth opportunity**: Early-stage company (27 people) with clear trajectory to clinical manufacturing — offers outsized ownership and impact for early hires.
- **Perks & environment**: Fast-paced startup environment; cross-disciplinary collaboration between hardware, software, and biology teams; close ties to Y Combinator and top-tier biotech investors.

## Sources
1. [mytos.bio](https://www.mytos.bio/)
2. [mytos.bio/about](https://www.mytos.bio/about)
3. [mytos.bio/team](https://www.mytos.bio/team)
4. [jobs.lever.co/mytos](https://jobs.lever.co/mytos)
5. [linkedin.com/company/mytosbio](https://linkedin.com/company/mytosbio)

## Other roles at Mytos

- [Manufacturing Lead (Hardware)](https://feeny.ai/job/manufacturing-lead-hardware-mytos-london-hece9emszmy3) — London, United Kingdom
- [Principal Scientist (PD/MSAT)](https://feeny.ai/job/principal-scientist-pd-msat-mytos-london-k1sg669m78rx) — London, United Kingdom
- [Chief of Staff](https://feeny.ai/job/chief-of-staff-mytos-london-hzjngkgttykk) — London, United Kingdom
- [Quality (QA) Lead - CDMO](https://feeny.ai/job/quality-qa-lead-cdmo-mytos-london-hvpy6dwzm2e1) — London, United Kingdom
- [Junior Mechanical Engineer (Summer 2026)](https://feeny.ai/job/junior-mechanical-engineer-summer-2026-mytos-london-czy4dsyhwkpr) — London, United Kingdom
- [Junior/Mid Software Engineer](https://feeny.ai/job/junior-mid-software-engineer-mytos-london-z5vvnb9pcger) — London, United Kingdom
- [Senior Product Designer](https://feeny.ai/job/senior-product-designer-mytos-london-kzjj94dtnkjd) — London, United Kingdom
- [General Opportunity](https://feeny.ai/job/general-opportunity-mytos-london-wb9h4jkeb87k) — London, United Kingdom
- [Engineering Technician](https://feeny.ai/job/engineering-technician-mytos-london-pvheyvc2nkjj) — London, United Kingdom
- [Senior Mechanical Engineer](https://feeny.ai/job/senior-mechanical-engineer-anduril-industries-sydney-new-south-wales-ks474e4wgamr) — Sydney New South Wales, Australia